Indication
Vulvar
1 clinical trial
3 products
Clinical trial
Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated MalignanciesStatus: Active (not recruiting), Estimated PCD: 2022-07-26
Product
PDS0101Product
M7824Product
NHS-IL12